NASDAQ:IRTC - Irhythm Technologies Stock Price, Price Target & More

$61.76 +0.11 (+0.18 %)
(As of 04/23/2018 04:00 PM ET)
Previous Close$61.65
Today's Range$61.45 - $63.01
52-Week Range$32.10 - $68.07
Volume176,469 shs
Average Volume207,252 shs
Market Capitalization$1.45 billion
P/E Ratio-47.65
Dividend YieldN/A
Beta1.01

About Irhythm Technologies (NASDAQ:IRTC)

Irhythm Technologies logoiRhythm Technologies, Inc., a digital healthcare company, provides ambulatory electrocardiogram (ECG) monitoring products for patients at risk for arrhythmias in the United States. The company offers Zio service, an ambulatory cardiac monitoring solution that combines a wire-free, patch-based, and wearable biosensor with a cloud-based data analytic platform to help physicians to monitor patients and diagnose arrhythmias. Its Zio XT monitor, a single-use, wire-free, and wearable patch-based biosensor, records patient's heartbeats and ECG data. The company was founded in 2006 and is headquartered in San Francisco, California.

Receive IRTC News and Ratings via Email

Sign-up to receive the latest news and ratings for IRTC and its competitors with MarketBeat's FREE daily newsletter.

Industry, Sector and Symbol

Industry Surgical & medical instruments
Sub-IndustryN/A
SectorMedical
SymbolNASDAQ:IRTC
CUSIPN/A
Phone415-632-5700

Debt

Debt-to-Equity Ratio0.41%
Current Ratio5.72%
Quick Ratio5.64%

Price-To-Earnings

Trailing P/E Ratio-47.65
Forward P/E Ratio-40.10
P/E GrowthN/A

Sales & Book Value

Annual Sales$98.51 million
Price / Sales14.79
Cash FlowN/A
Price / CashN/A
Book Value$3.46 per share
Price / Book17.85

Profitability

EPS (Most Recent Fiscal Year)($1.30)
Net Income$-29,420,000.00
Net Margins-29.87%
Return on Equity-34.44%
Return on Assets-22.04%

Miscellaneous

Employees575
Outstanding Shares23,590,000

How to Become a New Pot Stock Millionaire

Irhythm Technologies (NASDAQ:IRTC) Frequently Asked Questions

What is Irhythm Technologies' stock symbol?

Irhythm Technologies trades on the NASDAQ under the ticker symbol "IRTC."

How were Irhythm Technologies' earnings last quarter?

Irhythm Technologies Inc (NASDAQ:IRTC) announced its earnings results on Wednesday, February, 14th. The company reported ($0.48) earnings per share for the quarter, missing the Thomson Reuters' consensus estimate of ($0.35) by $0.13. The company had revenue of $28.20 million for the quarter, compared to analysts' expectations of $26.79 million. Irhythm Technologies had a negative return on equity of 34.44% and a negative net margin of 29.87%. The company's quarterly revenue was up 50.8% compared to the same quarter last year. During the same period last year, the business earned ($0.37) EPS. View Irhythm Technologies' Earnings History.

When is Irhythm Technologies' next earnings date?

Irhythm Technologies is scheduled to release their next quarterly earnings announcement on Wednesday, May, 2nd 2018. View Earnings Estimates for Irhythm Technologies.

What price target have analysts set for IRTC?

7 Wall Street analysts have issued 12-month price targets for Irhythm Technologies' shares. Their predictions range from $60.00 to $80.00. On average, they expect Irhythm Technologies' share price to reach $71.1667 in the next year. View Analyst Ratings for Irhythm Technologies.

What are Wall Street analysts saying about Irhythm Technologies stock?

Here are some recent quotes from research analysts about Irhythm Technologies stock:
  • 1. Northland Securities analysts commented, "We note that this was a physician-initiated study and funded by Bardy. Also, it is important to take this study within the context of an initial study which could provide clues for a larger head-head study, providing important clues for the sensitivity & specificity of R-R wave vs. P-wave analysis in ambulatory ECG monitoring." (4/16/2018)
  • 2. According to Zacks Investment Research, "iRhythm Technologies, Inc. is a digital healthcare company. It focuses on the provision of ambulatory electrocardiogram, monitoring for patients at risk for arrhythmias primarily in the United States. The company offers ZIO Service, a platform which provides wearable biosensor with cloud-based data analytics that distill data from heartbeats into clinically actionable information. iRhythm Technologies, Inc. is headquartered in San Francisco, California. " (1/3/2018)
  • 3. Canaccord Genuity analysts commented, "We expect these data, assuming the read-out of the full study data follows suit (which we expect), will build IRTC’s case with payers, paving the way ultimately for prospective screening with Zio in a brand new, 3- million-patient TAM. While not in our model at all, we think over time, payors will cover Zio for screening of high-risk patients defined by the mSToPs study. We reiterate our BUY rating and $59 price target." (11/14/2017)

Who are some of Irhythm Technologies' key competitors?

Who are Irhythm Technologies' key executives?

Irhythm Technologies' management team includes the folowing people:
  • Mr. Kevin M. King, Pres , CEO & Director (Age 62)
  • Mr. Matthew C. Garrett, CFO & Chief Accounting Officer (Age 50)
  • Mr. David A. Vort, Exec. VP of Sales (Age 52)
  • Dr. Derrick Sung Ph.D., Exec. VP of Strategy and Corp. Devel. (Age 45)
  • Ms. Judith C. Lenane RN, MHA, Chief Clinical Officer and Exec. VP of Operations (Age 59)

When did Irhythm Technologies IPO?

(IRTC) raised $76 million in an IPO on Thursday, October 20th 2016. The company issued 5,400,000 shares at $13.00-$15.00 per share. J.P. Morgan and Morgan Stanley served as the underwriters for the IPO and Canaccord Genuity and BTIG were co-managers.

Has Irhythm Technologies been receiving favorable news coverage?

News stories about IRTC stock have been trending somewhat positive recently, Accern reports. The research firm identifies negative and positive press coverage by analyzing more than 20 million blog and news sources. Accern ranks coverage of public companies on a scale of negative one to one, with scores closest to one being the most favorable. Irhythm Technologies earned a news sentiment score of 0.17 on Accern's scale. They also assigned media stories about the company an impact score of 47.92 out of 100, meaning that recent press coverage is somewhat unlikely to have an effect on the stock's share price in the near term.

How do I buy shares of Irhythm Technologies?

Shares of IRTC can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.

What is Irhythm Technologies' stock price today?

One share of IRTC stock can currently be purchased for approximately $61.76.

How big of a company is Irhythm Technologies?

Irhythm Technologies has a market capitalization of $1.45 billion and generates $98.51 million in revenue each year. The company earns $-29,420,000.00 in net income (profit) each year or ($1.30) on an earnings per share basis. Irhythm Technologies employs 575 workers across the globe.

How can I contact Irhythm Technologies?

Irhythm Technologies' mailing address is 650 TOWNSEND STREET SUITE 500, SAN FRANCISCO CA, 94103. The company can be reached via phone at 415-632-5700 or via email at [email protected]


MarketBeat Community Rating for Irhythm Technologies (IRTC)

Community Ranking:  2.5 out of 5 (star star half star)
Outperform Votes:  96 (Vote Outperform)
Underperform Votes:  95 (Vote Underperform)
Total Votes:  191
MarketBeat's community ratings are surveys of what our community members think about Irhythm Technologies and other stocks. Vote "Outperform" if you believe IRTC will outperform the S&P 500 over the long term. Vote "Underperform" if you believe IRTC will underperform the S&P 500 over the long term. You may vote once every thirty days.

Analyst Ratings

Irhythm Technologies (NASDAQ:IRTC) Price Target and Consensus Rating

  (How are Consensus Ratings Calculated?)
7 Wall Street analysts have issued ratings and price targets for Irhythm Technologies in the last 12 months. Their average twelve-month price target is $71.1667, suggesting that the stock has a possible upside of 15.23%. The high price target for IRTC is $80.00 and the low price target for IRTC is $60.00. There are currently 2 hold ratings and 5 buy ratings for the stock, resulting in a consensus rating of "Buy."
Today30 Days Ago90 Days Ago180 Days Ago
Consensus Rating: BuyBuyBuyBuy
Consensus Rating Score: 2.712.712.752.75
Ratings Breakdown: 0 Sell Rating(s)
2 Hold Rating(s)
5 Buy Rating(s)
0 Strong Buy Rating(s)
0 Sell Rating(s)
2 Hold Rating(s)
5 Buy Rating(s)
0 Strong Buy Rating(s)
0 Sell Rating(s)
1 Hold Rating(s)
3 Buy Rating(s)
0 Strong Buy Rating(s)
0 Sell Rating(s)
1 Hold Rating(s)
3 Buy Rating(s)
0 Strong Buy Rating(s)
Consensus Price Target: $71.1667$71.1667$67.6667$41.00
Price Target Upside: 15.23% upside10.78% upside26.84% upside15.88% downside

Irhythm Technologies (NASDAQ:IRTC) Consensus Price Target History

Price Target History for Irhythm Technologies (NASDAQ:IRTC)

Irhythm Technologies (NASDAQ:IRTC) Analyst Ratings History

Show:
DateBrokerageActionRatingPrice TargetImpact on Share PriceDetails
4/16/2018Northland SecuritiesReiterated RatingHold$60.00LowView Rating Details
3/12/2018Canaccord GenuityReiterated RatingBuy -> Buy$68.00 -> $80.00LowView Rating Details
3/5/2018BMO Capital MarketsInitiated CoverageOutperform$76.00MediumView Rating Details
2/15/2018JPMorgan ChaseBoost Price TargetOverweight -> Overweight$62.00 -> $67.00HighView Rating Details
12/4/2017Royal Bank of CanadaInitiated CoverageOutperform$79.00HighView Rating Details
12/1/2017Dougherty & CoInitiated CoverageNeutral -> NeutralMediumView Rating Details
11/3/2017Morgan StanleyBoost Price TargetOverweight$50.00 -> $65.00N/AView Rating Details
12/6/2016BTIG ResearchDowngradeBuy -> NeutralN/AView Rating Details
(Data available from 4/23/2016 forward)

Earnings

Irhythm Technologies (NASDAQ:IRTC) Earnings History and Estimates Chart

Earnings by Quarter for Irhythm Technologies (NASDAQ:IRTC)

Irhythm Technologies (NASDAQ:IRTC) Earnings Estimates

Current Year EPS Consensus Estimate: $-1.54 EPS
Next Year EPS Consensus Estimate: $-1.08 EPS

Irhythm Technologies (NASDAQ IRTC) Earnings History by Quarter

DateQuarterConsensus EstimateActual EPSRevenue EstimateActual RevenueRelease LinkConference CallDetails
5/2/2018($0.42)N/AView Earnings Details
2/14/2018Q4 2017($0.35)($0.48)$26.79 million$28.20 millionViewListenView Earnings Details
11/1/2017Q3 2017($0.34)($0.29)$24.30 million$25.04 millionViewN/AView Earnings Details
8/2/2017Q2 2017($0.31)($0.29)$22.10 million$23.85 millionViewListenView Earnings Details
5/3/2017Q1 2017($0.36)($0.24)$19.13 million$21.40 millionViewListenView Earnings Details
2/15/2017Q416($0.28)($0.37)$17.33 million$18.70 millionViewListenView Earnings Details
12/5/2016Q3 2016($0.27)($2.80)$16.52 million$16.80 millionViewListenView Earnings Details
(Earnings results data provided by Zacks Investment Research)

Dividends

Irhythm Technologies (NASDAQ:IRTC) Dividend History by Quarter

AnnouncedPeriodAmountYieldEx-Dividend DateRecord DatePayable Date
(Data available from 1/1/2013 forward)

Insider Trades

Irhythm Technologies (NASDAQ IRTC) Insider Trading and Institutional Ownership History

Insider Ownership Percentage: 5.05%
Institutional Ownership Percentage: 98.01%
Insider Trading History for Irhythm Technologies (NASDAQ:IRTC)
Institutional Ownership by Quarter for Irhythm Technologies (NASDAQ:IRTC)

Irhythm Technologies (NASDAQ IRTC) Insider Trading History

Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionShares Held After TransactionDetails
3/9/2018Vijay K. LathiDirectorSell114,018$66.44$7,575,355.92View SEC Filing  
3/8/2018David A VortEVPSell935$67.01$62,654.3522,221View SEC Filing  
2/26/2018Kevin M KingInsiderSell60,000$64.52$3,871,200.00201,842View SEC Filing  
2/23/2018Raymond W ScottDirectorSell8,499$65.55$557,109.458,499View SEC Filing  
2/21/2018Vijay K LathiDirectorSell169,000$62.41$10,547,290.00View SEC Filing  
1/5/2018Matthew C GarrettCFOSell42,910$59.17$2,538,984.7036,085View SEC Filing  
12/7/2017Vijay K. LathiDirectorSell150,000$52.57$7,885,500.00View SEC Filing  
12/5/2017Vijay K. LathiDirectorSell57,430$52.41$3,009,906.30View SEC Filing  
12/4/2017Matthew C GarrettCFOSell1,193$55.00$65,615.00View SEC Filing  
11/17/2017Vijay K LathiDirectorSell225,000$52.10$11,722,500.00View SEC Filing  
11/6/2017Kevin M KingInsiderSell60,000$51.85$3,111,000.00103,042View SEC Filing  
9/13/2017Vijay K LathiDirectorSell34,613$49.51$1,713,689.631,405View SEC Filing  
9/12/2017David A. VortEVPSell5,000$48.76$243,800.00View SEC Filing  
9/7/2017Raymond W ScottDirectorSell8,088$48.00$388,224.008,088View SEC Filing  
9/6/2017Raymond W ScottDirectorSell4,661$48.02$223,821.224,661View SEC Filing  
8/28/2017Raymond W ScottDirectorSell12,749$45.30$577,529.7012,749View SEC Filing  
8/7/2017Raymond W. ScottDirectorSell52,903$43.59$2,306,041.77View SEC Filing  
7/11/2017Kevin M. KingInsiderSell110,000$42.08$4,628,800.00View SEC Filing  
7/10/2017Matthew C. GarrettCFOSell25,086$42.06$1,055,117.16View SEC Filing  
6/8/2017Synergy Life Science PartnersMajor ShareholderSell350,000$37.43$13,100,500.00View SEC Filing  
6/8/2017Vijay K LathiDirectorSell430,624$37.59$16,187,156.16View SEC Filing  
5/16/2017Vijay K LathiDirectorSell645,000$34.70$22,381,500.00View SEC Filing  
(Data available from 1/1/2013 forward)

Headlines

Irhythm Technologies (NASDAQ IRTC) News Headlines

Source:
DateHeadline
Irhythm Technologies (IRTC) Rating Lowered to Sell at Zacks Investment ResearchIrhythm Technologies (IRTC) Rating Lowered to Sell at Zacks Investment Research
www.americanbankingnews.com - April 19 at 9:40 PM
iRhythm Technologies to Report First Quarter Financial Results on May 2, 2018iRhythm Technologies to Report First Quarter Financial Results on May 2, 2018
finance.yahoo.com - April 18 at 4:35 PM
Irhythm Technologies (IRTC) "Hold" Rating Reiterated at Northland SecuritiesIrhythm Technologies' (IRTC) "Hold" Rating Reiterated at Northland Securities
www.americanbankingnews.com - April 16 at 11:39 AM
Irhythm Technologies (IRTC) Upgraded by Zacks Investment Research to HoldIrhythm Technologies (IRTC) Upgraded by Zacks Investment Research to Hold
www.americanbankingnews.com - April 14 at 8:37 PM
Irhythm Technologies (IRTC) Downgraded to Sell at Zacks Investment ResearchIrhythm Technologies (IRTC) Downgraded to Sell at Zacks Investment Research
www.americanbankingnews.com - April 12 at 11:21 PM
Irhythm Technologies (IRTC) and Its Rivals Head to Head AnalysisIrhythm Technologies (IRTC) and Its Rivals Head to Head Analysis
www.americanbankingnews.com - April 10 at 5:18 PM
iRhythm Technologies Appoints UCLA and Cedars-Sinai Professor C. Noel Bairey Merz, M.D. to its Board of DirectorsiRhythm Technologies Appoints UCLA and Cedars-Sinai Professor C. Noel Bairey Merz, M.D. to its Board of Directors
finance.yahoo.com - April 10 at 4:21 PM
Comparing T2 Biosystems (TTOO) & Irhythm Technologies (IRTC)Comparing T2 Biosystems (TTOO) & Irhythm Technologies (IRTC)
www.americanbankingnews.com - April 10 at 3:25 PM
Irhythm Technologies (IRTC) Downgraded by Zacks Investment Research to SellIrhythm Technologies (IRTC) Downgraded by Zacks Investment Research to Sell
www.americanbankingnews.com - April 9 at 8:25 AM
 Brokerages Anticipate Irhythm Technologies Inc (IRTC) Will Announce Quarterly Sales of $28.75 Million Brokerages Anticipate Irhythm Technologies Inc (IRTC) Will Announce Quarterly Sales of $28.75 Million
www.americanbankingnews.com - April 9 at 2:16 AM
Irhythm Technologies (IRTC) Raised to Buy at Zacks Investment ResearchIrhythm Technologies (IRTC) Raised to Buy at Zacks Investment Research
www.americanbankingnews.com - April 7 at 11:36 PM
 Analysts Expect Irhythm Technologies Inc (IRTC) to Post -$0.42 Earnings Per Share Analysts Expect Irhythm Technologies Inc (IRTC) to Post -$0.42 Earnings Per Share
www.americanbankingnews.com - April 7 at 7:12 PM
Head to Head Analysis: Obalon Therapeutics (OBLN) vs. Irhythm Technologies (IRTC)Head to Head Analysis: Obalon Therapeutics (OBLN) vs. Irhythm Technologies (IRTC)
www.americanbankingnews.com - April 7 at 5:44 PM
Irhythm Technologies (IRTC) Rating Lowered to Hold at Zacks Investment ResearchIrhythm Technologies (IRTC) Rating Lowered to Hold at Zacks Investment Research
www.americanbankingnews.com - April 7 at 2:14 PM
Irhythm Technologies Inc (IRTC) Receives Average Recommendation of "Hold" from AnalystsIrhythm Technologies Inc (IRTC) Receives Average Recommendation of "Hold" from Analysts
www.americanbankingnews.com - April 5 at 10:16 AM
Analyzing Valeritas (VLRX) and Irhythm Technologies (IRTC)Analyzing Valeritas (VLRX) and Irhythm Technologies (IRTC)
www.americanbankingnews.com - April 1 at 11:28 PM
Irhythm Technologies (IRTC) Lowered to "Sell" at Zacks Investment ResearchIrhythm Technologies (IRTC) Lowered to "Sell" at Zacks Investment Research
www.americanbankingnews.com - March 30 at 11:42 PM
Irhythm Technologies (IRTC) versus Its Rivals Critical ContrastIrhythm Technologies (IRTC) versus Its Rivals Critical Contrast
www.americanbankingnews.com - March 30 at 3:12 PM
How Financially Strong Is iRhythm Technologies Inc (NASDAQ:IRTC)?How Financially Strong Is iRhythm Technologies Inc (NASDAQ:IRTC)?
finance.yahoo.com - March 30 at 9:43 AM
Contrasting Irhythm Technologies (IRTC) & Five Star Senior Living (FVE)Contrasting Irhythm Technologies (IRTC) & Five Star Senior Living (FVE)
www.americanbankingnews.com - March 27 at 3:20 PM
ValuEngine Upgrades Irhythm Technologies (IRTC) to HoldValuEngine Upgrades Irhythm Technologies (IRTC) to Hold
www.americanbankingnews.com - March 25 at 4:48 PM
$28.75 Million in Sales Expected for Irhythm Technologies Inc (IRTC) This Quarter$28.75 Million in Sales Expected for Irhythm Technologies Inc (IRTC) This Quarter
www.americanbankingnews.com - March 23 at 3:04 AM
 Analysts Expect Irhythm Technologies Inc (IRTC) Will Announce Earnings of -$0.42 Per Share Analysts Expect Irhythm Technologies Inc (IRTC) Will Announce Earnings of -$0.42 Per Share
www.americanbankingnews.com - March 21 at 7:18 PM
BidaskClub Lowers Irhythm Technologies (IRTC) to HoldBidaskClub Lowers Irhythm Technologies (IRTC) to Hold
www.americanbankingnews.com - March 16 at 11:34 PM
Irhythm Technologies (IRTC) Earns Hold Rating from Northland SecuritiesIrhythm Technologies (IRTC) Earns Hold Rating from Northland Securities
www.americanbankingnews.com - March 14 at 4:40 PM
Vijay K. Lathi Sells 114,018 Shares of Irhythm Technologies Inc (IRTC) StockVijay K. Lathi Sells 114,018 Shares of Irhythm Technologies Inc (IRTC) Stock
www.americanbankingnews.com - March 12 at 7:21 PM
Canaccord Genuity Reaffirms "Positive" Rating for Irhythm Technologies (IRTC)Canaccord Genuity Reaffirms "Positive" Rating for Irhythm Technologies (IRTC)
www.americanbankingnews.com - March 12 at 3:28 PM
Irhythm Technologies Inc (IRTC) Given Consensus Rating of "Buy" by BrokeragesIrhythm Technologies Inc (IRTC) Given Consensus Rating of "Buy" by Brokerages
www.americanbankingnews.com - March 11 at 10:14 AM
Insider Selling: Irhythm Technologies Inc (IRTC) EVP Sells 935 Shares of StockInsider Selling: Irhythm Technologies Inc (IRTC) EVP Sells 935 Shares of Stock
www.americanbankingnews.com - March 9 at 3:29 PM
IRhythm Technologies Is Breaking Ground In Cardiac Monitoring, Says New Sell-Side BullIRhythm Technologies Is Breaking Ground In Cardiac Monitoring, Says New Sell-Side Bull
finance.yahoo.com - March 6 at 4:42 PM
BMO Capital Markets Initiates Coverage on Irhythm Technologies (IRTC)BMO Capital Markets Initiates Coverage on Irhythm Technologies (IRTC)
www.americanbankingnews.com - March 5 at 8:24 PM
Irhythm Technologies Inc (IRTC) Holdings Raised by Sectoral Asset Management IncIrhythm Technologies Inc (IRTC) Holdings Raised by Sectoral Asset Management Inc
www.americanbankingnews.com - March 5 at 3:35 PM
How Do Analysts See iRhythm Technologies Inc (NASDAQ:IRTC) Performing Over The Next Few Years?How Do Analysts See iRhythm Technologies Inc (NASDAQ:IRTC) Performing Over The Next Few Years?
finance.yahoo.com - March 3 at 9:34 AM
Irhythm Technologies Inc (IRTC) is Next Century Growth Investors LLCs 4th Largest PositionIrhythm Technologies Inc (IRTC) is Next Century Growth Investors LLC's 4th Largest Position
www.americanbankingnews.com - March 2 at 5:58 PM
iRhythm Technologies Inc (IRTC) Files 10-K for the Fiscal Year Ended on December 31, 2017iRhythm Technologies Inc (IRTC) Files 10-K for the Fiscal Year Ended on December 31, 2017
finance.yahoo.com - March 2 at 9:28 AM
Ascend Capital LLC Purchases 26,839 Shares of Irhythm Technologies Inc (IRTC)Ascend Capital LLC Purchases 26,839 Shares of Irhythm Technologies Inc (IRTC)
www.americanbankingnews.com - March 2 at 5:04 AM
Irhythm Technologies Inc (IRTC) Insider Kevin M. King Sells 60,000 SharesIrhythm Technologies Inc (IRTC) Insider Kevin M. King Sells 60,000 Shares
www.americanbankingnews.com - February 28 at 3:21 PM
Irhythm Technologies Inc (IRTC) Director Sells $557,109.45 in StockIrhythm Technologies Inc (IRTC) Director Sells $557,109.45 in Stock
www.americanbankingnews.com - February 26 at 9:08 PM
Irhythm Technologies (IRTC) Stock Rating Upgraded by BidaskClubIrhythm Technologies (IRTC) Stock Rating Upgraded by BidaskClub
www.americanbankingnews.com - February 25 at 5:28 PM
Vijay K. Lathi Sells 169,000 Shares of Irhythm Technologies Inc (IRTC) StockVijay K. Lathi Sells 169,000 Shares of Irhythm Technologies Inc (IRTC) Stock
www.americanbankingnews.com - February 22 at 6:14 PM
Free Post Earnings Research Report: Baxters Quarterly Sales Grew 5%; Adjusted EPS Advanced 12%Free Post Earnings Research Report: Baxter's Quarterly Sales Grew 5%; Adjusted EPS Advanced 12%
finance.yahoo.com - February 22 at 9:25 AM
FY2018 EPS Estimates for Irhythm Technologies Inc Cut by Dougherty & Co (IRTC)FY2018 EPS Estimates for Irhythm Technologies Inc Cut by Dougherty & Co (IRTC)
www.americanbankingnews.com - February 19 at 5:58 AM
Irhythm Technologies Inc (IRTC) Expected to Announce Earnings of -$0.29 Per ShareIrhythm Technologies Inc (IRTC) Expected to Announce Earnings of -$0.29 Per Share
www.americanbankingnews.com - February 15 at 11:10 PM
Irhythm Technologies (IRTC) Stock Rating Reaffirmed by JPMorgan Chase & Co.Irhythm Technologies (IRTC) Stock Rating Reaffirmed by JPMorgan Chase & Co.
www.americanbankingnews.com - February 15 at 11:18 AM
iRhythm Technologies (IRTC) CEO Kevin King on Q4 2017 Results - Earnings Call TranscriptiRhythm Technologies' (IRTC) CEO Kevin King on Q4 2017 Results - Earnings Call Transcript
seekingalpha.com - February 15 at 8:51 AM
Irhythm Technologies (IRTC) Announces Quarterly  Earnings Results, Misses Expectations By $0.13 EPSIrhythm Technologies (IRTC) Announces Quarterly Earnings Results, Misses Expectations By $0.13 EPS
www.americanbankingnews.com - February 14 at 9:12 PM
iRhythm Technologies Announces Fourth Quarter and Full Year 2017 Financial Results and Provides Full Year 2018 Financial OutlookiRhythm Technologies Announces Fourth Quarter and Full Year 2017 Financial Results and Provides Full Year 2018 Financial Outlook
finance.yahoo.com - February 14 at 4:42 PM
Irhythm Technologies Inc (IRTC) Given Consensus Recommendation of "Hold" by BrokeragesIrhythm Technologies Inc (IRTC) Given Consensus Recommendation of "Hold" by Brokerages
www.americanbankingnews.com - February 14 at 10:38 AM
iRhythm Technologies to Present at the RBC Global Healthcare ConferenceiRhythm Technologies to Present at the RBC Global Healthcare Conference
finance.yahoo.com - February 8 at 9:00 AM
Irhythm Technologies (IRTC) Set to Announce Earnings on WednesdayIrhythm Technologies (IRTC) Set to Announce Earnings on Wednesday
www.americanbankingnews.com - February 7 at 4:38 AM

SEC Filings

Irhythm Technologies (NASDAQ:IRTC) SEC Filings

This page is loading this company's SEC Filings. Please wait...

Social Media

Financials

Irhythm Technologies (NASDAQ:IRTC) Income Statement, Balance Sheet and Cash Flow Statement

Chart

Irhythm Technologies (NASDAQ IRTC) Stock Chart for Monday, April, 23, 2018

Loading chart…

This page was last updated on 4/23/2018 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.